Qing Liu
Education
Ph.D. and M.S., epidemiology, Brown University; B.S./M.D., preventative medicine, Peking University
Summary of Experience
Dr. Liu is an epidemiologist with expertise in biostatistics, clinical medicine, and public health. She has experience with real-world data analyses, including administrative claims and hospital-based database analyses, clinical trial analyses, and pharmacoeconomic modeling. Her research focuses on the evaluation and comparison of clinical and economic outcomes in a broad range of therapeutic areas, including hematology, oncology, rheumatology, and infectious diseases and vaccines. Dr. Liu’s work includes cost-effectiveness analyses, systematic literature reviews, comparative effectiveness research, and studies evaluating health care resource use and costs. Her work has been published in peer-reviewed journals and presented at conferences on medical and health care research. Prior to joining Analysis Group, Dr. Liu was a graduate student researcher at Brown University, where she focused on the interaction of genetic variants and dietary lipids in the field of cardio-metabolic health outcomes.
- 
                                                        Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancerProstate Cancer and Prostatic Diseases, 2024 
 2024George DJ, Ramaswamy K, Yang H, Liu Q, Zhang A, Greatsinger A, Ivanova J, Thompson B, Emir B, Hong A, Freedland SJ 
- 
                                                        Incidence of pneumococcal disease in children ≤48 months old in the United States: 1998–2019Vaccine, 2024 
 2024Mohanty S, Done N, Liu Q, Song Y, Wang T, Gaburo K, Sarpong EM, White M, Weaver JP, Signorovitch J, Weiss T 
- 
                                                        Economic Burden of Acute Otitis Media, Pneumonia, and Invasive Pneumococcal Disease in Children in the United States after the Introduction of 13-Valent Pneumococcal Conjugate Vaccines During 2014-2018BMC Health Services Research, 2023 
 2023Hu T, Song Y, Done N, Mohanty S, Liu Q, Sarpong EM, Lemus-Wirtz E, Signorovitch J, Weiss T 
- 
                                                        Incidence of Non-Invasive All-Cause Pneumonia in Children in the United States before and after the Introduction of Pneumococcal Conjugate Vaccines: A Retrospective Claims Database AnalysisPneumonia, 2023 
 2023Hu T, Sarpong EM, Song Y, Done N, Liu Q, Lemus-Wirtz E, Signorovitch J, Mohanty S, Weiss T 
- 
                                                        Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspectiveBlood Advances, 2023 
 2023Maziarz RT, Gergis U, Edwards ML, Song Y, Liu Q, Anderson A, Signorovitch JE, Manghani R, Simantov R, Shin H, Sivaraman S 
- 
                                                        Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodTransplantation and Cellular Therapy, 2022 
 2022Lin C, Sajeev G, Stiff PJ, Brunstein CG, Cutler C, Sanz G, Lindemans CA, Rezvani AR, Hanna R, Koh LP, Maziarz RT, Hwang WYK, Song Y, Liu Q, Manghani R, Sivaraman S, Signorovitch J, Horwitz ME, Sung AD 
- 
                                                        Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018BMC Public Health, 2022 
 2022Hu T, Song Y, Done N, Liu Q, Sarpong EM, Lemus-Wirtz E, Signorovitch J, Mohanty S, Weiss T 
- 
                                                        Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United StatesLeukemia & Lymphoma, 2022 
 2022Maziarz RT, Yang H, Liu Q, Wang T, Zhao J, Lim S, Lee S, Dalal A, Bollu V 
- 
                                                        Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018BMS Infectious Diseases, 2022 
 2022Hu T, Done N, Petigara T, Mohanty S, Song Y, Liu Q, Lemus-Wirtz E, Signorovitch J, Sarpong E, Weiss T 
- 
                                                        Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in JapanTransplantation and Cellular Therapy, 2021 
 2021Wakase S, Teshima T, Zhang J, Ma Q, Fujita T, Yang H, Chai X, Qi CZ, Liu Q, Wu EQ, Igarashi A 
- 
                                                    June 6, 2024
- 
                                                    October 23, 2023
- 
                                                    October 15, 2021
